XJPX6823
Market cap191mUSD
Jan 21, Last price
2,423.00JPY
1D
-0.57%
1Q
10.99%
Jan 2017
49.57%
Name
Rion Co Ltd
Chart & Performance
Profile
Rion Co., Ltd. manufactures, sells, and maintains hearing instruments, medical equipment, sound and vibration measuring instruments, particle counters, and related parts and equipment in Japan. The company's audiological equipment includes hearing instruments, such as analog and digital BTE, trimmer digital BTE, in-the-ear ready and custom made, and analog body aid instruments, as well as waterproof hearing instruments; and medical equipment comprising audiometers and OAE screeners. Its sound and vibration measuring instruments include sound level meters, vibration meters, seismometers, frequency analyzers, microphones and accelerometers, recorders, and other products. The company's particle counters comprise air and liquid- borne particle counters, and viable particle counters. Its products are primarily used in the applications of environment-related administration, electronics, semiconductors, pharmaceutical, and food manufacturing industries. The company was formerly known as Kobayashi-Riken Seisakusho Ltd. and changed its name to Rion Co., Ltd. in 1960. Rion Co., Ltd. was incorporated in 1944 and is headquartered in Kokubunji, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 25,726,997 7.79% | 23,868,087 5.44% | 22,635,697 10.60% | |||||||
Cost of revenue | 13,633,968 | 13,053,697 | 12,184,326 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 12,093,029 | 10,814,390 | 10,451,371 | |||||||
NOPBT Margin | 47.01% | 45.31% | 46.17% | |||||||
Operating Taxes | 865,438 | 585,242 | 942,090 | |||||||
Tax Rate | 7.16% | 5.41% | 9.01% | |||||||
NOPAT | 11,227,591 | 10,229,148 | 9,509,281 | |||||||
Net income | 2,652,379 47.39% | 1,799,586 -19.28% | 2,229,464 36.19% | |||||||
Dividends | (553,588) | (565,615) | (528,887) | |||||||
Dividend yield | 1.50% | 2.38% | 1.85% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 11,201 | 11,608 | ||||||||
Long-term debt | 11,733 | 17,258 | 28,460 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 1,043,718 | 1,643,744 | 1,844,742 | |||||||
Net debt | (6,141,799) | (6,880,502) | (9,062,216) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 2,857,805 | 1,783,938 | 2,841,768 | |||||||
CAPEX | (2,691,195) | (2,063,082) | (1,086,583) | |||||||
Cash from investing activities | (2,652,892) | (3,246,066) | (951,931) | |||||||
Cash from financing activities | (565,548) | (577,320) | (541,832) | |||||||
FCF | 8,635,151 | 8,200,213 | 9,463,815 | |||||||
Balance | ||||||||||
Cash | 5,025,613 | 5,371,961 | 7,719,284 | |||||||
Long term investments | 1,127,919 | 1,537,000 | 1,383,000 | |||||||
Excess cash | 4,867,182 | 5,715,557 | 7,970,499 | |||||||
Stockholders' equity | 22,452,943 | 24,155,926 | 22,844,436 | |||||||
Invested Capital | 25,387,902 | 22,263,397 | 18,348,013 | |||||||
ROIC | 47.12% | 50.38% | 52.22% | |||||||
ROCE | 38.07% | 36.67% | 37.64% | |||||||
EV | ||||||||||
Common stock shares outstanding | 12,307 | 12,298 | 12,289 | |||||||
Price | 2,998.00 55.26% | 1,931.00 -17.20% | 2,332.00 -22.27% | |||||||
Market cap | 36,896,386 55.37% | 23,747,438 -17.13% | 28,657,948 -22.23% | |||||||
EV | 30,754,587 | 16,866,936 | 19,595,732 | |||||||
EBITDA | 12,994,833 | 11,558,424 | 11,155,772 | |||||||
EV/EBITDA | 2.37 | 1.46 | 1.76 | |||||||
Interest | 1,945 | 2,129 | 1,936 | |||||||
Interest/NOPBT | 0.02% | 0.02% | 0.02% |